Mencevax
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Mencevax, covering 2017-10-06 to 2019-06-07. Get the full timeline:
Most recent: Clinical Trial Update: The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination [Phase 3]